• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » LabCorp names Dr. Brian Caveney as enterprise-wide chief medical officer

LabCorp names Dr. Brian Caveney as enterprise-wide chief medical officer

August 29, 2017
CenterWatch Staff

LabCorp, a global life sciences company, announced that Dr. Brian Caveney, a nationally recognized health-policy expert who currently serves as chief medical officer of Blue Cross and Blue Shield of North Carolina (Blue Cross NC), will fill a newly created role as enterprise-wide chief medical officer of LabCorp, effective Sept. 25. Caveney will report to David P. King, chairman and CEO of LabCorp.

“Brian is a nationally respected thought leader who brings deep expertise to LabCorp on critical topics, including health policy, healthcare financing, regulatory initiatives, value-based care models, and clinical standards of care,” said King. “Whether in our nation’s capital or at the state level, he is a sought-after voice when health policy is being crafted, and for good reason. In addition to being a highly accomplished managed-care executive, Brian was a practicing physician and holds degrees in medicine, health policy and administration, and law. I can think of no finer choice to become our first enterprise-wide chief medical officer.”

In the newly created role, Caveney will have broad responsibility for LabCorp’s medical and scientific strategy, including serving as primary medical representative for the company externally, defining global standards for medical and scientific activities across LabCorp’s Diagnostics and Drug Development businesses, and enhancing a culture of medical and scientific excellence.

Added King: “LabCorp has become an important participant in the global healthcare and life sciences discussion, and having an enterprise-wide chief medical officer of Brian’s national stature will enhance our position and strengthen our influence on critical decisions that will affect our industry in the years ahead.”

Caveney joined Blue Cross NC in 2011. In addition to various roles in the Healthcare Division of the core health plan, Caveney also served as chief clinical officer of Mosaic Health Solutions, a wholly owned subsidiary of Blue Cross NC for strategic investments in diversified health solutions businesses. Prior to joining Blue Cross NC, Caveney was a practicing physician and assistant professor at Duke University Medical Center and also provided consulting services for several companies in the Research Triangle Park region.

Caveney is a sought-after speaker at national conferences; has participated in sessions at the U.S. Food and Drug Administration, the National Academy of Sciences, The Advisory Board Company, the North Carolina Institute of Medicine, and various state committees and panels; and is a frequent lecturer at Duke University, the University of North Carolina, and North Carolina State University. In addition, he has authored at least 20 papers, was editor-in-chief of the three-volume treatise “Occupational Injuries and Illnesses,” and has served as an editorial reviewer for several healthcare industry journals.

Caveney holds an M.D. from the West Virginia University School of Medicine, a J.D. from the West Virginia University College of Law and an M.P.H. in health policy and administration from the University of North Carolina at Chapel Hill. He completed his residency at Duke University Medical Center and is board-certified in preventive medicine, with a specialty in occupational and environmental medicine. He is the past president of the Southeastern Atlantic College of Occupational and Environmental Medicine and continues to hold an active law license in North Carolina.

“LabCorp’s reputation for enhancing patient care through comprehensive diagnostics and now cutting-edge therapeutic advances is known around the world,” said Caveney. “I am excited to join LabCorp’s outstanding leadership team in pursuit of the company’s inspiring mission to improve health and improve lives.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing